Malaga Cove Capital, LLC Gilead Sciences, Inc. Transaction History

Malaga Cove Capital, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $1.47 Million - $1.67 Million	-22,616 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $7,581 - $8,179	-112 Reduced 0.49%	22,616 $1.58 Million
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $76,735 - $83,844	-1,209 Reduced 5.05%	22,728 $1.57 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $29,100 - $33,203	-485 Reduced 1.99%	23,937 $1.55 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $40,674 - $46,346	-718 Reduced 2.86%	24,422 $1.43 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $20,306 - $25,532	327 Added 1.32%	25,140 $1.59 Million
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $10,344 - $12,012	143 Added 0.58%	24,813 $1.91 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $379,725 - $486,373	6,063 Added 32.58%	24,670 $1.84 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $189,111 - $208,016	3,069 Added 19.75%	18,607 $1.21 Million
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $47,007 - $51,888	-752 Reduced 4.62%	15,538 $985,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $148,488 - $166,512	2,400 Added 17.28%	16,290 $1.1 Million
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $6,440 - $7,215	-103 Reduced 0.74%	13,890 $903,000
Q4 2018 Feb 04, 2019	BUY	$60.54 - $79.0 $412,035 - $537,674	6,806 Added 94.7%	13,993 $871,000
Q3 2018 Oct 15, 2018	BUY	$71.28 - $78.92 $12,687 - $14,047	178 Added 2.54%	7,187 $563,000
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $454,743 - $530,441	7,009 New	7,009 $497,000

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.